Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,344,898
-$9,974,855 QoQ
Shares Held
2,394,145
-29.6% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 71.76181893744949.ToString("F0")%
Shared 0.ToString("F0")%
None 28.238181062550517.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $398,774,467 across 27 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
731,609 | $96,382,169 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,838,437 | $55,373,722 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
60,541 | $35,899,602 | |
| 4 | ZTS |
Zoetis Inc.
|
295,063 | $34,879,397 | |
| 5 | VTRS |
Viatris Inc
This page
|
2,394,145 | $32,344,898 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
502,406 | $25,969,366 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
506,521 | $24,388,985 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
625,304 | $20,678,803 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,344,898 | 2,394,145 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $42,319,753 | 3,399,177 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,409,691 | 1,051,484 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,592,463 | 1,074,184 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,116,499 | 1,161,481 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $11,735,930 | 942,645 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $9,544,604 | 822,102 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $18,449,736 | 1,735,629 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $21,459,069 | 1,797,242 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $19,132,332 | 1,766,605 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $14,468,228 | 1,467,366 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $17,647,773 | 1,768,314 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $29,176,382 | 3,032,888 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $30,126,005 | 2,706,739 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $17,474,707 | 2,051,022 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,869,303 | 178,539 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,541,657 | 325,520 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $10,632,969 | 785,881 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $12,105,583 | 893,401 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $9,300,274 | 650,824 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $11,301,730 | 809,000 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $7,828,260 | 417,730 | Shares | Sole | 2021-02-01 | |
| No filing history on record for this holder in this stock. | ||||||